Characteristic | Overall | Vascular Access on First Dialysis: | |||||||
---|---|---|---|---|---|---|---|---|---|
Any | Catheter only | AVF/AVG in place | AVF/AVG used | ||||||
Attributed Cause of ESRD: | |||||||||
SLE | Other | SLE | Other | SLE | Other | SLE | Other | ||
N (%) | 67,748 (100 %) | 517 (0.8 %) | 66,961 (99.2 %) | 384 (0.9 %) | 40,527 (99.1 %) | 85 (0.6 %) | 13,409 (99.4 %) | 48 (0.4 %) | 13,025 (99.6 %) |
Demographic | |||||||||
Mean (SD) age, years | 64.1 (14.9) | 40.3 (15.3)a | 64.3 (14.8)a | 39.0 (15.0)a | 64.1 (15.3)a | 41.7 (15.8)a | 63.8 (14.3)a | 48.6 (14.2)a | 65.4 (13.6)a |
Female, n (%) | 29,276 (43.4 %) | 410 (79.3 %)a | 28,866 (43.1 %)a | 315 (82.0 %)a | 17,951 (44.3 %)a | 64 (75.3 %)a | 5,675 (42.3 %)a | 31 (64.6 %)b | 7,785 (59.8 %)b |
Race/ethnicity, % | |||||||||
Non-Hispanic white | 34,731 (51.5 %) | 129 (25.0 %)a | 34,602 (51.7 %)a | 89 (23.2 %)a | 20,813 (51.4 %) a | 22 (25.9 %)a | 6,644 (49.6 %)a | 18 (37.5 %) | 7,145 (54.9 %) |
Black | 20,221 (30.0 %) | 284 (54.9 %)a | 19,937 (29.8 %)a | 221 (57.6 %)a | 11,984 (29.6 %)a | 42 (49.4 %)a | 4,108 (30.6 %)a | 21 (43.8 %) | 3,845 (29.5 %) |
Hispanic white | 8,722 (12.9 %) | 72 (13.9 %)a | 8,650 (12.9 %)a | 56 (14.6 %)a | 5,526 (13.6 %)a | 10 (11.8 %)a | 1,829 (13.6 %)a | —c | 1,295 (9.9 %) |
Other | 3,804 (5.6 %) | 32 (6.2 %)a | 3,772 (5.6 %)a | 18 (4.7 %)a | 2,204 (5.4 %)a | 11 (12.9 %)a | 828 (6.2 %)a | —c | 740 (5.7 %) |
Insurance at dialysis start, % | |||||||||
Private | 16,546 (24.5 %) | 137 (26.5 %)a | 16,409 (24.5 %)a | 93 (24.2 %)a | 9,441 (23.3 %)a | 25 (29.4 %)b | 3,387 (25.3 %)b | 19 (39.6 %) | 3,264 (25.1 %) |
Medicare/other | 27,159 (40.3 %) | 104 (20.1 %)a | 27,055 (40.4 %)a | 67 (17.5 %)a | 16,037 (39.6 %)a | 21 (24.7 %)b | 5,315 (39.6 %)b | 16 (33.3 %) | 3,581 (27.5 %) |
Medicaid | 18,183 (27.0 %) | 201 (38.9 %)a | 17.982 (26.9 %)a | 160 (41.7 %)a | 10,897 (26.9 %)a | 32 (37.7 %)b | 3,821 (28.5 %)b | —c | 5,703 (43.8 %) |
None | 5,590 (8.3 %) | 75 (14.5 %)a | 5,515 (8.2 %)a | 64 (16.7 %)a | 4,152 (10.3 %)a | —c | 886 (6.6 %)b | —c | 477 (3.7 %) |
Clinical | |||||||||
Pre-ESRD nephrology care, % | 38,937 (65.7 %) | 307 (67.0 %) | 38,630 (65.7 %) | 200 (60.2 %)b | 18,042 (52.4 %)b | 64 (81.0 %) | 9,034 (74.4 %) | 43 (91.5 %) | 11,554 (94.3 %) |
Mean (SD) BMI, kg/m2 | 29.5 (7.9) | 27.3 (7.5)a | 29.5 (7.9)a | 27.2 (7.5)a | 29.3 (8.0)a | 27.7 (6.9)a | 29.9 (7.9)a | 27.3 (8.3)b | 29.8 (7.7)b |
Congestive heart failure, % | 22,893 (33.9 %) | 85 (16.4 %)a | 22,808 (34.1 %)a | 59 (15.4 %)a | 14,292 (35.3 %)a | 18 (21.2 %)b | 4,819 (35.9 %)b | —c | 3,697 (28.4 %) |
Diabetes, % | 38,918 (57.7 %) | 62 (12.0 %)a | 38,856 (58.0 %)a | 44 (11.5 %)a | 22,940 (56.6 %)a | 12 (14.1 %)a | 8,401 (62.7 %)a | —c | 7,515 (57.7 %)a |
Peripheral vascular disease, % | 9,569 (14.2 %) | 21 (4.1 %)a | 9,548 (14.3 %)a | 16 (4.2 %)a | 5,494 (13.6 %)a | —c | 2,267 (16.9 %)b | —c | 1,787 (13.7 %)b |
Smoking, % | 4,369 (6.5 %) | 26 (5.0 %) | 4,343 (6.5 %) | 13 (3.4 %)b | 2,645 (6.5 %)b | 10 (11.8 %) | 889 (6.6 %) | —c | 810 (6.2 %) |
Transplanted within 1 year, % | 853 (1.3 %) | 13 (2.5 %)b | 840 (1.3 %)b | —c | 429 (1.1 %)b | —c | 160 (1.2 %) | —c | 252 (1.9 %) |
Recovered renal function within 1 year, % | 1048 (1.6 %) | 13 (2.5 %) | 1035 (1.6 %) | 11 (2.9 %) | 909 (2.2 %) | —c | 85 (0.6 %) | —c | 41 (0.3 %) |